Biotalys Enters into Academic Collaborations with Key Scientific Leaders in Europe and U.S.
08 Février 2024 - 7:00AM
Biotalys Enters into Academic Collaborations with Key Scientific
Leaders in Europe and U.S.
Biotalys (Euronext – BTLS), an Agricultural Technology (AgTech)
company developing protein-based biocontrol solutions for crop
protection, today announced that the company has entered into
several academic collaborations with leading researchers in plant
pathology in both Europe and the U.S.
Biotalys is developing a series of biocontrols
to support growers in protecting their crops from pests and
diseases. The company’s R&D program BioFun-4
was initiated last year to develop a biofungicide against
Phytophthora infestans, an oomycete (water mould) that causes late
blight/potato blight, a serious disease that particularly affects
fruit and vegetable crops and potatoes. Biotalys has now entered
into a research collaboration agreement with the University of
Aberdeen (United Kingdom), under which Biotalys will sponsor a
three-year PhD project in the Oomycete Laboratory of Prof. Pieter
van West, Chair in Mycology, a leader in the field of plant and
animal pathogenic oomycetes. This project will deepen the expertise
in oomycetes at the molecular level and fits well with Biotalys’
highly targeted strategy of applying a discovery method based on
defined molecular targets, as core of its AGROBODY™ 2.0 technology
platform.
The company also announced two new academic
collaborations related to BioFun-7, its ongoing
R&D program in partnership with the Bill & Melinda Gates
Foundation and focused on developing biocontrols against leafspot
disease for cowpeas and other legumes. The first collaboration is
with the Instituto Superior de Agronomia (ISA) at the University of
Lisbon (Portugal) to isolate and characterize new strains of
Cercospora canescens, the target fungal disease of the BioFun-7
program. The work led by Dr. Filipa Monteiro at Linking Landscape,
Environment, Agriculture and Food (LEAF) labs (e.g., Coffee Rust
Research Centre (CIFC), Prof. Dora Batista) will enable Biotalys to
test the effectiveness of its molecules in infection experiments.
The collaboration was initiated in the second half of 2023 and is
planned to run for two years.
The second agreement related to
BioFun-7 is with the University of
California-Davis (U.S.) and the lab of Prof. Ioannis Stergiopoulos
at the department of Plant Pathology. Prof. Stergiopoulos dedicates
his research to the understanding of fungal plant pathogens and to
translating this knowledge into effective intervention strategies
for disease control. In this collaboration, Prof. Stergiopoulos’s
lab will perform a functional analysis of antifungal targets in
select plant pathogens, pertinent to the BioFun-7 program.
Dr. Carlo Boutton, Chief Scientific
Officer of Biotalys, commented: “With these collaborations
we have announced today, we continue to build on the strong
scientific foundation of our programs and technology. I am a firm
believer of the synergies that can be created between the expertise
and excellent research in academia and industry, and the announced
new collaborations are examples of that vision. We continuously
seek to partner with experts in all aspects of our field as we work
to bring novel, sustainable crop protection products to growers. We
are excited about the work these researchers will be doing with
us.”
Biotalys already has academic partnerships with
the University of Ghent and the Flemish Institute of Biotech VIB.
In addition, the company previously received a grant from the
Flemish Agency for Innovation and Entrepreneurship (VLAIO) for a
PhD project (so-called Baekeland mandate) to conduct research
around novel protein-based fungicides.
The company also has a Scientific Advisory
Committee of leading experts, formed in late 2022 to support the
company’s continued growth, accelerate product pipeline efforts and
deepen scientific partnership initiatives.
About Biotalys
Biotalys is an Agricultural Technology (AgTech)
company developing protein-based biocontrol solutions for the
protection of crops and food and aiming to provide alternatives to
conventional chemical pesticides for a more sustainable and safer
food supply. Based on its novel AGROBODY™ technology platform,
Biotalys is developing a strong and diverse pipeline of effective
product candidates with a favorable safety profile that aim to
address key crop pests and diseases across the whole value chain,
from soil to plate. Biotalys was founded in 2013 as a spin-off from
the VIB (Flanders Institute for Biotechnology) and has been listed
on Euronext Brussels since July 2021. The company is based in the
biotech cluster in Ghent, Belgium. More information can be found on
www.biotalys.com.
For further information, please
contact:
Toon Musschoot, Head of IR &
CommunicationsT: +32 (0)9 274 54 00E: IR@biotalys.com
Important Notice
Biotalys, its business, prospects and financial
position remain exposed and subject to risks and
uncertainties. A description of and reference to these risks
and uncertainties can be found in the 2022 annual report on the
consolidated annual accounts and the half-year report for 2023.
This announcement contains statements which are
"forward-looking statements" or could be considered as such. These
forward-looking statements can be identified by the use of
forward-looking terminology, including the words ‘aim’, 'believe',
'estimate', 'anticipate', 'expect', 'intend', 'may', 'will',
'plan', 'continue', 'ongoing', 'possible', 'predict', 'plans',
'target', 'seek', 'would' or 'should', and contain statements made
by the company regarding the intended results of its strategy. By
their nature, forward-looking statements involve risks and
uncertainties and readers are warned that none of these
forward-looking statements offers any guarantee of future
performance. Biotalys’ actual results may differ materially from
those predicted by the forward-looking statements. Biotalys makes
no undertaking whatsoever to publish updates or adjustments to
these forward-looking statements, unless required to do so by
law.
- Biotalys_Academic collaborations_Press Release
- Biotalys_academische samenwerkingen
Biotalys (EU:BTLS)
Graphique Historique de l'Action
De Fév 2025 à Mar 2025
Biotalys (EU:BTLS)
Graphique Historique de l'Action
De Mar 2024 à Mar 2025